Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer

被引：0
|
作者：
Shari B. Goldfarb
Volkan Turan
Giuliano Bedoschi
Enes Taylan
Nadia Abdo
Tessa Cigler
Heejung Bang
Sujita Patil
Maura N. Dickler
Kutluk H. Oktay
机构：
[1] Memorial Sloan Kettering Cancer Center,Department of Obstetrics and Gynecology and Reproductive Sciences
[2] Weill Cornell Medical Center,Department of Obstetrics and Gynecology
[3] Yale University School of Medicine,Department of Obstetrics and Gynecology
[4] Health and Technology University School of Medicine,Division of Biostatistics, Department of Public Health Sciences
[5] Ribeirao Preto School of Medicine,undefined
[6] University of Sao Paulo,undefined
[7] University of California,undefined
来源：
Breast Cancer Research and Treatment | 2021年 / 185卷
关键词：
Drug therapy; Breast neoplasms; Anti-mullerian hormone; Fertility preservation; Ovarian reserve;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：165 / 173
页数：8
相关论文
共 50 条
  • [31] Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
    Baum, M
    Buzdar, AU
    Cuzick, J
    Forbes, J
    Houghton, J
    Klijn, JGM
    Sahmoud, T
    LANCET, 2002, 359 (9324): : 2131 - 2139
  • [32] Cyclophosphamide-Free Adjuvant Chemotherapy for Ovarian Protection in Young Women With Breast Cancer: A Randomized Phase 3 Trial
    Yu, Ke-Da
    Ge, Jing-Yu
    Liu, Xi-Yu
    Mo, Miao
    He, Min
    Shao, Zhi-Ming
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (10): : 1352 - 1359
  • [33] Cyclophosphamide-Free Adjuvant Chemotherapy for the Potential Prevention of Premature Ovarian Insufficiency and Infertility in Young Women With Breast Cancer
    Lambertini, Matteo
    Partridge, Ann H.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (10): : 1274 - 1276
  • [34] Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: Meta-analysis of quality-adjusted survival
    Gelber, RD
    Cole, BF
    Goldhirsch, A
    Rose, C
    Fisher, B
    Osborne, CK
    Boccardo, F
    Gray, R
    Gordon, NH
    Bengtsson, NO
    Sevelda, P
    LANCET, 1996, 347 (9008): : 1066 - 1071
  • [35] Protective effect of goserelin on ovarian reserve during (neo)adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China
    Wang, Siyuan
    Pei, Lin
    Hu, Taobo
    Jia, Mei
    Wang, Shu
    HUMAN REPRODUCTION, 2021, 36 (04) : 976 - 986
  • [36] TAMOXIFEN AND CHEMOTHERAPY MORE EFFECTIVE THAN TAMOXIFEN ALONE IN TREATING BREAST-CANCER
    RAUB, W
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (01): : 19 - 19
  • [37] Ovarian cysts in women receiving tamoxifen for breast cancer
    Mourits, MJE
    de Vries, EGE
    Willemse, PHB
    ten Hoor, KA
    Hollema, H
    Sluiter, WJ
    de Bruijn, HWA
    van der Zee, AGJ
    BRITISH JOURNAL OF CANCER, 1999, 79 (11-12) : 1761 - 1764
  • [38] Ovarian cysts in women receiving tamoxifen for breast cancer
    M J E Mourits
    E G E de Vries
    P H B Willemse
    K A ten Hoor
    H Hollema
    W J Sluiter
    H W A de Bruijn
    A G J van der Zee
    British Journal of Cancer, 1999, 79 : 1761 - 1764
  • [39] Adjuvant Chemotherapy for Breast Cancer in Older Women
    Spurrell, E.
    Wilson, P.
    Gallagher, C.
    Slater, S.
    Roylance, R.
    CLINICAL ONCOLOGY, 2016, 28 (08) : 542 - 542
  • [40] Adjuvant chemotherapy for breast cancer in older women
    Berry, Donald A.
    WOMENS HEALTH, 2009, 5 (05) : 453 - 457
12345